Canada Pension Plan Investment Board
IMGN

Canada Pension Plan Investment Board’s Immunogen Inc IMGN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-586,990
Closed -$17.4M – 1281
2023
Q4 		$17.4M Buy
+586,990
New +$11.7M 0.02% 418
2020
Q1 		– Sell
-1,224,900
Closed -$6.25M – 1510
2019
Q4 		$6.25M Buy
1,224,900
+524,900
+75% +$1.78M 0.01% 574
2019
Q3 		$1.69M Buy
+700,000
New +$1.86M ﹤0.01% 877

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Canada Pension Plan Investment Board's IMGN Position: Q1 2024 in Review

Canada Pension Plan Investment Board sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 586,990 shares — an estimated $17.4M sold.

Canada Pension Plan Investment Board first reported a position in IMGN in Q3 2019 and held it in 3 quarters. The position peaked at $17.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Canada Pension Plan Investment Board reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 586,990 Immunogen Inc shares in Q1 2024, an estimated $17.4M.
  • Canada Pension Plan Investment Board first reported a position in Immunogen Inc in Q3 2019 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Immunogen Inc position peaked at $17.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2024, filed 14 May 2024.